US 10449178
Glucocorticoid receptor modulators to treat pancreatic cancer
granted A61KA61K31/03A61K31/18
Quick answer
US patent 10449178 (Glucocorticoid receptor modulators to treat pancreatic cancer) held by Corcept Therapeutics Incorporated expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/03, A61K31/18, A61K31/337, A61K31/416